14 February 2025 - Most individuals in the US are concerned about prescription drug affordability. ...
1 February 2025 - State Medicaid agencies can now apply to participate in a new model that supports voluntary, outcomes-based agreements ...
17 January 2025 - List of drugs account for $41 billion in annual Medicare spending, Biden administration says. ...
20 December 2024 - Under the Inflation Reduction Act, some people with Medicare will pay less for some Part B ...
4 December 2024 - Today, the Biden-Harris Administration announced that two drug manufacturers with FDA approved gene therapies for sickle ...
26 November 2024 - Today, the CMS is proposing actions in the Medicare Advantage and Medicare Part D prescription drug programs ...
13 November 2024 - Medicare beneficiaries are often inadequately represented in clinical studies supporting US Food and Drug Administration medical product ...
11 November 2024 - Medicare Advantage patients in the last year of life were far more likely to switch to traditional ...
29 October 2024 - The historic Inflation Reduction Act of 2022 has fundamentally improved the affordability of and access to prescription ...
18 October 2024 - Novo Nordisk today announced that the EMA's CHMP has adopted a positive opinion, recommending approval of ...
16 October 2024 - The Federal Government has proven that it can navigate the difficult process of identifying drugs for price ...
13 September 2024 - The Centers for Medicare and Medicaid Services’ coverage with evidence development policy allows the agency to provide ...
30 July 2024 - The deadline for announcing how much Medicare lowered drug prices in the first year of negotiation is ...
1 August 2024 - A federal court backed the Biden administration’s Medicare drug price negotiation program on Wednesday, the latest ...
28 July 2024 - Luye Pharma today announced that the US FDA has approved the company's Erzofri (paliperidone palmitate) extended-release injectable ...